Abstract: An analog of mycothiazole and pseudotrienic acid B were synthesized efficiently by using ring-closing metathesis or cross-metathesis as key reactions.
INTRODUCTION
Over the past few years, natural products have continued to be of interest owing to their wide spectrum of biological and pharmaceutical properties. However, the natural supply of these compounds is usually extremely scarce and full biological evaluation cannot be achieved, thus necessitating synthetic efforts to provide sustainable material. For our part, we have been interested in the synthesis of an analog of mycothiazole and in the total synthesis of pseudotrienic acid B.
MYCOTHIAZOLE AND ANALOGS
Mycothiazole was first isolated in 1988 from the marine sponge Spongia mycofijiensis collected from the Vanuatu islands [1] , and this compound was also detected in the extracts of another marine sponge of the genus Dactylospongia [2] . Mycothiazole was found to exhibit an antihelminthic activity in vitro as well as a rather selective toxicity against a small-cell lung cancer line [1, 3] . The structure of mycothiazole was initially established by the analysis of its NMR and high-resolution electron impact mass spectrometry (HREIMS) spectra [1] . However, a revised structure for mycothiazole was recently published on the basis of nuclear Overhauser effect (NOE) experiments and analysis of a higher-field 1 H NMR spectrum (600 MHz) [4] . The only difference between the previous and the revised structure lies in the configuration of the C15-C16 disubstituted double bond that is actually (Z) in mycothiazole (Fig. 1) . As we were involved in the synthesis of mycothiazole before revision of its structure, we have achieved the synthesis of compound I, which corresponds to the originally proposed structure of this natural product. We have to point out that one synthesis of compound I was previously reported in 2000 [5] .
Compound I is constituted by a central 2,4-disubstituted thiazole. A 2,5-hexadienyl side chain substitutes the C4 position of the heterocycle, whereas the side chain at C2 includes a nitrogen substituent at C13 (methyl carbamate), a gem-dimethyl-substituted carbon (C6) and a homoallylic conjugated (Z)-dienol subunit (C7 to C11-C20) with the (R) absolute configuration at C7.
The homoallylic conjugated (Z)-dienol subunit is a remarkable structural feature of mycothiazole, which is also encountered in other biologically active natural products. Therefore, a methodology was developed to synthesize such subunits from readily available homoallylic alcohols through the intermediacy of unsaturated sultones. Thus, when a homoallylic alcohol of type A was treated with allylsulfonyl chloride (Et 3 N, tetrahydrofuran (THF), -15 °C), the corresponding unsaturated sulfonate of type B was formed and subsequently underwent ring-closing metathesis by treatment with Grubbs second-generation catalyst II [6] (C 6 H 6 , 70 °C) to afford the corresponding unsaturated sultone C in good yield [7] [8] [9] [10] . The sultone could be alkylated at the α-position of the sulfonyl group (n-BuLi, THF, -78°C then R'X) and the resulting alkylated sultone D was metalated (n-BuLi, THF, -78 °C) to produce an organolithium reagent which was treated with ICH 2 As this methodology allowed access to homoallylic conjugated (Z)-dienols from readily available homoallylic alcohols in four steps and with satisfactory overall yields [8] , it has been included in our retrosynthetic analysis of the originally proposed structure of mycothiazole (compound I). The methyl carbamate moiety at C13 could be installed by a Schmidt reaction applied to the carboxylic acid of type G in which the elaboration of the conjugated (Z)-dienol moiety was envisaged from the corresponding homoallylic alcohol derivative of type H by using the previously described methodology. The introduction of the side chain at C4 in compound H should be achieved from the 2-substituted 4-bromothiazole J which, in turn, would be synthesized from the readily available 2,4-dibromothiazole 1 (Scheme 2).
In order to introduce the side chain at C2 on the thiazole ring, 2,4-dibromothiazole 1 was treated with prenylmagnesium chloride, which reacts chemoselectively and with complete allylic transposition (S E 2' process) to produce the 2,4-disubstituted thiazole 2. The terminal olefin in compound 2 was subjected to an oxidative cleavage to afford aldehyde 3 (OsO 4 , NMO, then NaIO 4 ), and this latter compound was treated with allylmagnesium bromide to produce the secondary alcohol 4. Compound 4 was transformed in four steps into the bromide 5 (protection as a tert-butyldimethylsilyl (TBS) ether, homologation at C4 by lithium-bromine exchange and formylation with dimethylformamide (DMF), reduction to the alcohol and bromination) which was then subjected to a Stille coupling with (E)-1-tributylstannylpenta-1,4-diene [PdCl 2 (MeCN) 2 , NMP, room temperature (rt)] to elaborate the nonconjugated dienic side chain at C4. After deprotection of the hydroxyl group at C7, the resulting homoallylic alcohol 6 was converted into the unsaturated sultone 7, which subsequently produced the homoallylic conjugated (Z)-dienol 8 upon sequential alkylations, first with a functionalized alkyl iodide and then with ICH 2 MgCl [8] . Four steps were then necessary to transform 9 into the originally proposed structure of mycothiazole I. After hydrolysis of the dimethyl acetal, the resulting aldehyde was oxidized to the corresponding carboxylic acid, which was converted into the acyl azide by treatment with diphenylphosphoryl azide (DPPA, Et 3 N, toluene, rt). Subsequent thermolysis induced the Curtius rearrangement to the corresponding isocyanate whose methanolysis finally led to compound I (Scheme 3) [9, 10] .
The total (racemic) synthesis of the originally proposed structure of mycothiazole I was achieved in 18 steps from 2,4-dibromothiazole 1 with an overall yield of 5 %. It is worth noting that a formal enantioselective access to I was also demonstrated through the synthesis of the homoallylic alcohol 4 in high optical purity (ee = 99 %) by using an enantioselective allyltitanation [9, 10] .
With the four fragments in hands, the stage was set to probe the envisaged end game of the synthesis. At first, the carboxylic acid 14 was coupled with the aminotrienic ester 11 to afford amide 23 in 96 % yield. In order to build the C1-C17 fragment of pseudotrienic acid B, the N,O-acetonide and the tert-butyloxycarbonyl group in compound 23 were successively cleaved (p-TsOH, MeOH leading to 24 then TFA, CH 2 Cl 2 ) and the obtained free aminoalcohol was subsequently coupled with the carboxylic acid 18 under classical peptide coupling conditions. The resulting vinyl iodide 25 was then involved in a Stille cross-coupling reaction with vinyl stannane 22, catalyzed by PdCl 2 (MeCN) 2 , which successfully produced the core structure of pseudotrienic acid B, i.e., ester 26 (51 % yield). Finally, after a simple saponification of 26 with LiOH, the expected pseudotrienic acid B was isolated in 75 % yield. The spectroscopic data were in agreement with those reported in the literature for the natural product (Scheme 6). Thus, a concise, efficient, and highly convergent stereoselective synthesis of pseudotrienic acid B has been achieved with a longest linear sequence of 10 steps from methyl sorbate 9 with 5.8 % overall yield [18] . To our knowledge, this constitutes the first total synthesis of this naturally occurring molecule.
By using very simple methodologies such as ring-closing metathesis and cross-metathesis reactions, efficient stereoselective syntheses of biologically active natural products as well as analogs can be achieved.
